Medical specialists from France tagged as investigators in clinical trials studying Squamous Cell Carcinoma of Head and Neck

Total 123 results

Agnès DUPRET BORIES, Dr
Seen in:
- Toulouse, IUCT-O
Trials:
- NCT04725396 (Principal Investigator)
Conditions:
- Oropharynx Squamous Cell Carcinoma;
- Oral Cavity Squamous Cell Carcinoma
Alain PREVOST, Dr
Seen in:
- Reims, Institut Jean Godinot
Trials:
- NCT04747054 (Principal Investigator)
Conditions:
- Squamous Cell Carcinoma of Head and Neck
Alexandre BOZEC, Pr
Seen in:
- Nice, Centre Antoine Lacassagne
Trials:
- NCT04725396 (Principal Investigator)
Conditions:
- Oropharynx Squamous Cell Carcinoma;
- Oral Cavity Squamous Cell Carcinoma
Alexandre COUTTE, MD
Seen in:
- Amiens, CHU d'AMIENS
- Amiens, Centre Hospitalier d'Amiens
- Picardie, Amiens, CHU Amiens
- Picardie, Amiens, CHU Amiens Picardie
Trials:
- NCT03723967 (Principal Investigator)
- NCT03663725 (Sub-Investigator)
- NCT05762172 (Sub-Investigator)
- NCT05835804 (Sub-Investigator)
Conditions:
Alix MARHIC, MD
Seen in:
- Val De Marne, Villejuif, Gustave Roussy
Trials:
- NCT03406247 (Principal Investigator)
Conditions:
- Head and Neck Squamous Cell Carcinoma
Amaury Daste
Seen in:
- Bordeaux Cedex, GSK Investigational Site
- Bordeaux, CHU Bordeaux
- Bordeaux, CHU Bordeaux - Service d'Oncologie Médicale
- Bordeaux, CHU Hopitaux de Bordeaux - Hôpital Saint-André
- Bordeaux, CHU de Bordeaux - Groupe Hospitalier Saint-André - Hopital Saint-Andre
- Bordeaux, Hopital Saint Andre, CHU Bordeaux
- Bordeaux, Hôpital saint-André
Trials:
- NCT04420884 (Principal Investigator)
- NCT03088059 (Principal Investigator)
- NCT05386550 (Principal Investigator)
- NCT04417465 (Principal Investigator)
- NCT06062420 (Principal Investigator)
- NCT04747054 (Principal Investigator)
- NCT04868877 (Principal Investigator)
- NCT03356223 (Principal Investigator)
- NCT03526835 (Principal Investigator)
Conditions:
Anouchka MODESTO, Dr
Seen in:
- Toulouse, Institut Claudius Regaud
Trials:
- NCT04747054 (Principal Investigator)
Conditions:
- Squamous Cell Carcinoma of Head and Neck
Antoine Galmiche
Seen in:
- Picardie, Amiens, Amiens university hospital
- Picardie, Amiens, CHU Amiens Picardie
Trials:
- NCT05791149 (Sub-Investigator)
- NCT05835804 (Sub-Investigator)
Conditions:
Antoine Hollebecque
Seen in:
- Other, Villejuif Cedex, Institut Gustave Roussy
- Paris, Institut Gustave Roussy
- Villejuif Cedex, Institut Gustave Roussy
- Villejuif, Gustave Roussy
- Villejuif, Institut de Cancerologie Gustave Roussy
- Villejuif, Vaillant, Institut Gustave Roussy
Trials:
- NCT04752358 (Principal Investigator)
- NCT04389632 (Principal Investigator)
- NCT05948475 (Principal Investigator)
- NCT02912949 (Principal Investigator)
- NCT03526835 (Principal Investigator)
- NCT05615818 (Principal Investigator)
Conditions:
Antoine Italiano, MD, PhD
Seen in:
- Bordeaux, Institut Bergonié
Trials:
- NCT04868877 (Principal Investigator)
Conditions:
Arnaud DAMECOURT, Dr
Seen in:
- Montpellier, CHU Gui de Chauliac
Trials:
- NCT04725396 (Principal Investigator)
Conditions:
- Oropharynx Squamous Cell Carcinoma;
- Oral Cavity Squamous Cell Carcinoma
Aurelie BIET, MD
Seen in:
- Picardie, Amiens, CHU Amiens Picardie
Trials:
- NCT05835804 (Sub-Investigator)
Conditions:
Aurélie LAGRANGE, MD
Seen in:
- Dijon, CGFL
- Dijon, Centre Georges-Francois Leclerc
Trials:
- NCT04823377 (Principal Investigator)
- NCT03723967 (Principal Investigator)
Conditions:
Aurelie MOREIRA, MD
Seen in:
- Picardie, Amiens, CHU Amiens
- Picardie, Amiens, CHU Amiens Picardie
Trials:
- NCT05762172 (Sub-Investigator)
- NCT05813418 (Sub-Investigator)
- NCT05835804 (Sub-Investigator)
Conditions:
Benjamin LINOT, MD
Seen in:
- Nantes, Hopital Prive du Confluent
Trials:
- NCT03723967 (Principal Investigator)
Conditions:
- Squamous Cell Carcinoma of the Head and Neck
Benoit CALDERON, Dr
Seen in:
- Avignon, Institut Sainte Catherine
Trials:
- NCT04747054 (Principal Investigator)
Conditions:
- Squamous Cell Carcinoma of Head and Neck
Bernard DEVAUCHELLE, Pr
Seen in:
- Amiens, CHU Amiens
- Picardie, Amiens, CHU Amiens Picardie
Trials:
- NCT04886245 (Sub-Investigator)
- NCT05835804 (Sub-Investigator)
Conditions:
Bruno CHAUFFERT, Pr
Seen in:
- Picardie, Amiens, CHU Amiens Picardie
Trials:
- NCT05835804 (Sub-Investigator)
Conditions:
Camille Evrard
Seen in:
- Poitiers cedex, GSK Investigational Site
- Poitiers, CHU Poitiers - Hôpital la Milétrie - service d'oncologie médicale
Trials:
- NCT05386550 (Principal Investigator)
- NCT06256588 (Principal Investigator)
Conditions:
- Head and Neck Cancer;
- Neoplasms, Head and Neck
Carole Helissey, MD
Seen in:
- Ile De France, Saint-Mandé, Hôpital d'Instruction des Armées Bégin
- Saint-Mandé, Hôpital d'Instruction des Armées Bégin
Trials:
- NCT05551117 (Principal Investigator)
- NCT04868877 (Principal Investigator)
Conditions:
Caroline Even
Seen in:
- Other, Villejuif Cedex, Institut Gustave Roussy
- Villejuif Cedex, GSK Investigational Site
- Villejuif, Gustave Roussy
Trials:
- NCT03485209 (Principal Investigator)
- NCT04420884 (Principal Investigator)
- NCT03088059 (Principal Investigator)
- NCT06062420 (Principal Investigator)
- NCT04747054 (Sub-Investigator)
Conditions:
Caroline Robert, MD
Seen in:
- Paris, Institut Gustave Roussy
- Val De Marne, Villejuif, Gustave Roussy Cancer Campus Grand Paris
- Val de Marne, Villejuif, Gustave Roussy Cancer Campus Grand Paris
- Villejuif, Institut Gustave Roussy
Trials:
- NCT04050436 (Principal Investigator)
- NCT05280314 (Principal Investigator)
- NCT02517281 (Principal Investigator)
- NCT02105168 (Principal Investigator)
Conditions:
Cecile Vicier, MD, PhD
Seen in:
- Marseille, L'Institut Paoli - Calmettes
Trials:
- NCT04868877 (Principal Investigator)
Conditions:
Charles Dayen, MD
Seen in:
- Amiens, Clinique de l'Europe
Trials:
- NCT04868877 (Principal Investigator)
Conditions:

Clinical Trials on Squamous Cell Carcinoma of Head and Neck

Washington University School of Medicine
Merck Sharp & Dohme LLC

Active, not recruiting

Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma

Head and Neck Cancer | Squamous Cell Carcinoma of the Head and Neck | Cancer of Head and Neck | Carcinoma, Squamous Cell of Head and Neck | Neoplasms, Head and Neck | Squamous Cell Carcinoma, Head and Neck

United States
Bristol-Myers Squibb

Active, not recruiting

A Study of Nivolumab in Patients With Head and Neck Cancer. (ProNiHN)

Squamous Cell Carcinoma of the Head and Neck; Head and Neck Cancer; Head and Neck Carcinoma; Cancer of the Head and Neck

France
Washington University School of Medicine
Celgene Corporation

Active, not recruiting

Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC) (APA)

Head and Neck Cancer | Squamous Cell Carcinoma of the Head and Neck | Cancer of Head and Neck | Neoplasms, Head and Neck | Cancer of the Head and Neck | Carcinoma, Squamous Cell of the Head and Neck

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Recruiting

Quad Shot Radiotherapy in Combination With Immune Checkpoint Inhibition

Recurrent Head and Neck Squamous Cell Carcinoma | Advanced Head and Neck Squamous Cell Carcinoma | Metastatic Head-and-neck Squamous-cell Carcinoma | Locally Advanced Head and Neck Squamous Cell Carcinoma | Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck | Stage IV Cutaneous...

United States
University of Pittsburgh
National Cancer Institute (NCI)

Terminated

Safety and Efficacy of Radiation/Cetuximab Plus EGFR Antisense DNA for Head and Neck Squamous Cell Carcinoma

Squamous Cell Carcinoma of the Head and Neck | Squamous Cell Carcinoma, Head And Neck | Carcinoma, Squamous Cell of Head and Neck

United States
National Cancer Institute (NCI)

Not yet recruiting

Pembrolizumab + N-803 Alone or in Combination With PD-L1 t-haNK Cells for Resectable Head and Neck Squamous Cell Carcinoma

Stage II Squamous Cell Carcinoma of the Head and Neck | Stage III Squamous Cell Carcinoma of the Head and Neck | Stage IV Squamous Cell Carcinoma of the Head and Neck

United States
Eben Rosenthal
National Cancer Institute (NCI)

Completed

Panitumumab-IRDye800 Compared to Sentinel Node Biopsy and (Selective) Neck Dissection in Identifying Metastatic Lymph Nodes in Patients With Head&Neck Cancer

Head and Neck Cancer | Head and Neck Squamous Cell Carcinoma | Squamous Cell Carcinoma of the Head and Neck (SCCHN)

United States
Arnaud Bewley, MD
National Cancer Institute (NCI); Genentech, Inc.

Terminated

Atezolizumab Before Surgery for the Treatment of Regionally Metastatic Head and Neck Squamous Cell Cancer With an Unknown or Historic Primary Site

Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 | Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck | Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck

United States
James J Lee
AVEO Pharmaceuticals, Inc.

Completed

Ficlatuzumab and Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)

Squamous Cell Carcinoma of the Head and Neck | Squamous Cell Carcinoma, Head And Neck | Carcinoma, Squamous Cell of Head and Neck

United States
Washington University School of Medicine

Active, not recruiting

Mitomycin C in Patients With Incurable p16 Positive Oropharyngeal and p16 Negative Head and Neck Squamous Cell Carcinoma (HNSCC) Resistant to Standard Therapies

Squamous Cell Carcinoma of the Head and Neck | Squamous Cell Carcinoma, Head and Neck

United States

Medical specialists from France tagged as investigators in clinical trials studying Squamous Cell Carcinoma of Head and Neck

Clinical Trials on Squamous Cell Carcinoma of Head and Neck

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations